세계의 측방유동 어세이용 컴포넌트 시장 : 유형, 기술, 용도, 최종 용도별 예측(2025-2030년)

The Lateral Flow Assay Components Market was valued at USD 722.15 million in 2023, expected to reach USD 760.29 million in 2024, and is projected to grow at a CAGR of 5.25%, to USD 1,033.60 million by 2030.

Lateral flow assay components form the backbone of many diagnostic tests, including home pregnancy kits and rapid tests for infectious diseases. These components typically include the conjugate pad, nitrocellulose membrane with test and control lines, and absorbent pad. The necessity of these components arises from their role in providing quick, specific, and cost-effective diagnostic results. They have broad applications across healthcare sectors, particularly in disease diagnostics, environmental testing, food and beverage safety, and veterinary medicine. End-use sectors range from hospitals and clinical testing centers to research laboratories and at-home diagnostic test manufacturers. Key growth drivers for this market include the increasing prevalence of infectious diseases, the rise in demand for point-of-care testing, and technological advancements in diagnostics. The COVID-19 pandemic has amplified the need for rapid testing, accelerating interest and investment in lateral flow assays. Emerging opportunities include integrating advanced technologies like AI for result interpretation, developing multiplex tests, and expanding into mobile and remote diagnostics. Companies might consider partnerships to innovate around sensitivity and specificity challenges to capitalize on these opportunities. However, limitations like the potential for false negatives or positives and regulatory hurdles pose challenges. The growth might also be hampered by competition from alternative diagnostic technologies, such as polymerase chain reaction (PCR) and next-generation sequencing (NGS). To fuel innovation, the market should focus on improving assay sensitivity, reducing costs, and enhancing result time. Developing eco-friendly components could also attract market share from sustainability-conscious end-users. The market exhibits a dynamic nature driven by technological advancements and the increasing demand for rapid testing. Companies focusing on versatility, such as creating modular assay components that can be used across various platforms, can position themselves advantageously in this competitive landscape.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Lateral Flow Assay Components Market

The Lateral Flow Assay Components Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing prevalence of infectious diseases worldwide
  • Rising demand for food safety testing with growing concerns regarding foodborne illnesses
  • Growing demand for home-based and self-testing kits
• Market Restraints
  • Limited sensitivity and specificity associated with lateral flow assay components
• Market Opportunities
  • Advancements in lateral flow assay components to improve sensitivity, specificity, and detection limits
  • Growing inclination towards rapid and point-of-care testing
• Market Challenges
  • Cross-reactivity and false-positive/negative results with lateral flow assay components

Porter's Five Forces: A Strategic Tool for Navigating the Lateral Flow Assay Components Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Lateral Flow Assay Components Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Lateral Flow Assay Components Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Lateral Flow Assay Components Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Lateral Flow Assay Components Market

A detailed market share analysis in the Lateral Flow Assay Components Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Lateral Flow Assay Components Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Lateral Flow Assay Components Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Lateral Flow Assay Components Market

A strategic analysis of the Lateral Flow Assay Components Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Lateral Flow Assay Components Market, highlighting leading vendors and their innovative profiles. These include Abcam PLC, ACON Laboratories, Inc., Agilent Technologies, Inc., Beckman Coulter, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Biomerieux SA, DiaSorin S.p.A., EMD Millipore Corporation, Fujirebio Inc., GE Healthcare, Hoffmann-La Roche Ltd., Hologic, Inc., Horiba Ltd., Lonza Group, Luminex Corporation, Merck KGaA, Meridian Bioscience, Inc., Ortho Clinical Diagnostics, PerkinElmer Inc., Promega Corporation, QIAGEN GmbH, Randox Laboratories Ltd., Sartorius AG, Siemens Healthcare GmbH, Streck, Inc., Sysmex Corporation, Thermo Fisher Scientific, Inc., and Waters Corporation.

Market Segmentation & Coverage

This research report categorizes the Lateral Flow Assay Components Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Membranes and Pads.
• Based on Technique, market is studied across Competitive Assays, Multiplex Detection Assays, and Sandwich Assays.
• Based on Application, market is studied across Clinical Testing, Drug Development & Quality Testing, Food Safety & Environmental Testing, and Veterinary Diagnostics.
• Based on End-Use, market is studied across Medical Device Contract Manufacturers and Medical Device Manufacturers.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing prevalence of infectious diseases worldwide
    • 5.1.1.2. Rising demand for food safety testing with growing concerns regarding foodborne illnesses
    • 5.1.1.3. Growing demand for home-based and self-testing kits
  • 5.1.2. Restraints
    • 5.1.2.1. Limited sensitivity and specificity associated with lateral flow assay components
  • 5.1.3. Opportunities
    • 5.1.3.1. Advancements in lateral flow assay components to improve sensitivity, specificity, and detection limits
    • 5.1.3.2. Growing inclination towards rapid and point-of-care testing
  • 5.1.4. Challenges
    • 5.1.4.1. Cross-reactivity and false-positive/negative results with lateral flow assay components
• 5.2. Market Segmentation Analysis
  • 5.2.1. Type: Growing usage of lateral flow assay (LFA) membranes for tests requiring high sensitivity and specificity
  • 5.2.2. Technique: Rising significance of multiplex detection Assays to detect multiple targets
  • 5.2.3. Application: Increasing demand for lateral flow assays that quantify and provide reliable data during drug development & quality testing
  • 5.2.4. End-use: Growing potential of lateral flow assay components among medical device manufacturers to retain control over their product's quality
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Lateral Flow Assay Components Market, by Type

• 6.1. Introduction
• 6.2. Membranes
• 6.3. Pads

7. Lateral Flow Assay Components Market, by Technique

• 7.1. Introduction
• 7.2. Competitive Assays
• 7.3. Multiplex Detection Assays
• 7.4. Sandwich Assays

8. Lateral Flow Assay Components Market, by Application

• 8.1. Introduction
• 8.2. Clinical Testing
• 8.3. Drug Development & Quality Testing
• 8.4. Food Safety & Environmental Testing
• 8.5. Veterinary Diagnostics

9. Lateral Flow Assay Components Market, by End-Use

• 9.1. Introduction
• 9.2. Medical Device Contract Manufacturers
• 9.3. Medical Device Manufacturers

10. Americas Lateral Flow Assay Components Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Lateral Flow Assay Components Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Lateral Flow Assay Components Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. Leveraging Recent Acquisitions, EDX Medical Plans to Build Out Lateral Flow Assay Business
  • 13.3.2. MilliporeSigma Breaks Ground on Company's First Lateral Flow Membrane Production Facility in the United States
  • 13.3.3. In Less Than 12 Months, Jabil Helps the Optics Leader Launch Digital Testing Platform with Licensable Technology for Novel Applications
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abcam PLC
• 2. ACON Laboratories, Inc.
• 3. Agilent Technologies, Inc.
• 4. Beckman Coulter
• 5. Becton, Dickinson and Company
• 6. Bio-Rad Laboratories, Inc.
• 7. Biomerieux SA
• 8. DiaSorin S.p.A.
• 9. EMD Millipore Corporation
• 10. Fujirebio Inc.
• 11. GE Healthcare
• 12. Hoffmann-La Roche Ltd.
• 13. Hologic, Inc.
• 14. Horiba Ltd.
• 15. Lonza Group
• 16. Luminex Corporation
• 17. Merck KGaA
• 18. Meridian Bioscience, Inc.
• 19. Ortho Clinical Diagnostics
• 20. PerkinElmer Inc.
• 21. Promega Corporation
• 22. QIAGEN GmbH
• 23. Randox Laboratories Ltd.
• 24. Sartorius AG
• 25. Siemens Healthcare GmbH
• 26. Streck, Inc.
• 27. Sysmex Corporation
• 28. Thermo Fisher Scientific, Inc.
• 29. Waters Corporation